noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Rutgers, The State University of[...]

Researchers to Study Risk Factors for Drug Overdoses in Young Adults
Xencor Inc.

Xencor Presents Initial Plamotamab Data in Rheumatoid Arthritis at ACR[...]
The American National Red Cross

The “Letter” Patients Need Most? O

Healthcare

Immunitybio Inc.

11/09/2026 | Press release | Distributed by Public on 11/09/2026 06:02

ImmunityBio and Rafa Announce Israeli Ministry of Health Approval of ANKTIVA Plus BCG for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in Situ

Read this content

Click here to read the original version at the source's official website. The text of this article is not available at the moment.

Immunitybio Inc. published this content on November 09, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 09, 2026 at 12:10 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]